The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Despite the project’s success, Trump repeatedly lashed out at the FDA for not approving the first COVID shots even sooner.

The equity portion of the Abrdn Healthcare Investors Fund fell (gross of fees) but outperformed its custom benchmark over the ...

The top vaccine official at the US Food and Drug Administration resigned Friday, accusing Health Secretary Robert F. Kennedy ...

The top FDA official also criticized Kennedy on Friday over “undermining” the confidence in the vaccine against measles as ...

Dr. Peter Marks announced his intention to resign and retire as the director of the Center for Biologics Evaluation and ...

Dr. Peter Marks, the Food and Drug Administration's top vaccine official who played a crucial role in the development of COVID-19 vaccines during the pandemic, has resigned, with one source telling ...

The top vaccine official criticized the nation's top health official for letting 'misinformation and lies' to guide his ...

Pfizer (NYSE:PFE) and other pandemic-era favorites will be back in the investors’ crosshairs following the resignation of Dr.

The Food and Drug Administration’s top vaccine official, Peter Marks, resigned on Friday, citing what he called Health and ...

A top vaccine advisor at the FDA was forced to resign on Friday. In his resignation letter, Dr. Peter Marks wrote "truth and transparency are not desired," by HHS Secretary Robert F. Kennedy Jr.